世界の固形腫瘍がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Solid Tumor Cancer Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4884
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、108ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、固形腫瘍がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法、免疫療法、ホルモン療法、外科的処置）、用途別市場規模（乳がん、子宮頸がん、結腸直腸がん、肺がん、前立腺がん、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・固形腫瘍がん治療の市場動向
・企業の競争状況、市場シェア
・固形腫瘍がん治療の種類別市場規模と予測2016-2027（化学療法、標的療法、免疫療法、ホルモン療法、外科的処置）
・固形腫瘍がん治療の用途別市場規模と予測2016-2027（乳がん、子宮頸がん、結腸直腸がん、肺がん、前立腺がん、その他）
・固形腫瘍がん治療の北米市場規模2016-2027（アメリカ、カナダ）
・固形腫瘍がん治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・固形腫瘍がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・固形腫瘍がん治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・固形腫瘍がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AstraZeneca, Plc.、Amgen, Inc.、B. Braun Melsungen AG、Bristol Myers Squibb & Company、Eli Lilly & Company、F.Hoffman La-Roche Ltd.、Merck & Co., Inc.、Novartis、Pfizer, Inc.、Olympus Medical Systems）
・結論

An abnormal mass of tissue that usually does not contain cysts or liquid areas.

Market Analysis and Insights: Global Solid Tumor Cancer Treatment Market
The global Solid Tumor Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Solid Tumor Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Solid Tumor Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Solid Tumor Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Solid Tumor Cancer Treatment market.

Global Solid Tumor Cancer Treatment Scope and Market Size
Solid Tumor Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Solid Tumor Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Targeted Therapy
Immunotherapy
Hormone Therapy
Surgical Procedures

Segment by Application
Breast Cancer
Cervical Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca, Plc.
Amgen, Inc.
B. Braun Melsungen AG
Bristol Myers Squibb & Company
Eli Lilly & Company
F.Hoffman La-Roche Ltd.
Merck & Co., Inc.
Novartis
Pfizer, Inc.
Olympus Medical Systems

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Solid Tumor Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy
1.2.5 Hormone Therapy
1.2.6 Surgical Procedures
1.3 Market by Application
1.3.1 Global Solid Tumor Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Breast Cancer
1.3.3 Cervical Cancer
1.3.4 Colorectal Cancer
1.3.5 Lung Cancer
1.3.6 Prostate Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Solid Tumor Cancer Treatment Market Perspective (2016-2027)
2.2 Solid Tumor Cancer Treatment Growth Trends by Regions
2.2.1 Solid Tumor Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Solid Tumor Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Solid Tumor Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Solid Tumor Cancer Treatment Industry Dynamic
2.3.1 Solid Tumor Cancer Treatment Market Trends
2.3.2 Solid Tumor Cancer Treatment Market Drivers
2.3.3 Solid Tumor Cancer Treatment Market Challenges
2.3.4 Solid Tumor Cancer Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Solid Tumor Cancer Treatment Players by Revenue
3.1.1 Global Top Solid Tumor Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Solid Tumor Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Solid Tumor Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Solid Tumor Cancer Treatment Revenue
3.4 Global Solid Tumor Cancer Treatment Market Concentration Ratio
3.4.1 Global Solid Tumor Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Solid Tumor Cancer Treatment Revenue in 2020
3.5 Solid Tumor Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Solid Tumor Cancer Treatment Product Solution and Service
3.7 Date of Enter into Solid Tumor Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Solid Tumor Cancer Treatment Breakdown Data by Type
4.1 Global Solid Tumor Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Solid Tumor Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 Solid Tumor Cancer Treatment Breakdown Data by Application
5.1 Global Solid Tumor Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Solid Tumor Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Solid Tumor Cancer Treatment Market Size (2016-2027)
6.2 North America Solid Tumor Cancer Treatment Market Size by Type
6.2.1 North America Solid Tumor Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Solid Tumor Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Solid Tumor Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Solid Tumor Cancer Treatment Market Size by Application
6.3.1 North America Solid Tumor Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Solid Tumor Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Solid Tumor Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Solid Tumor Cancer Treatment Market Size by Country
6.4.1 North America Solid Tumor Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Solid Tumor Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Solid Tumor Cancer Treatment Market Size (2016-2027)
7.2 Europe Solid Tumor Cancer Treatment Market Size by Type
7.2.1 Europe Solid Tumor Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Solid Tumor Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Solid Tumor Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Solid Tumor Cancer Treatment Market Size by Application
7.3.1 Europe Solid Tumor Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Solid Tumor Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Solid Tumor Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Solid Tumor Cancer Treatment Market Size by Country
7.4.1 Europe Solid Tumor Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Solid Tumor Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Solid Tumor Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Solid Tumor Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Solid Tumor Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Solid Tumor Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Solid Tumor Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Solid Tumor Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Solid Tumor Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Solid Tumor Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Solid Tumor Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Solid Tumor Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Solid Tumor Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Solid Tumor Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Solid Tumor Cancer Treatment Market Size (2016-2027)
9.2 Latin America Solid Tumor Cancer Treatment Market Size by Type
9.2.1 Latin America Solid Tumor Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Solid Tumor Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Solid Tumor Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Solid Tumor Cancer Treatment Market Size by Application
9.3.1 Latin America Solid Tumor Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Solid Tumor Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Solid Tumor Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Solid Tumor Cancer Treatment Market Size by Country
9.4.1 Latin America Solid Tumor Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Solid Tumor Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Solid Tumor Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Solid Tumor Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Solid Tumor Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Solid Tumor Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Solid Tumor Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Solid Tumor Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Solid Tumor Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Solid Tumor Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Solid Tumor Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Solid Tumor Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Solid Tumor Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Solid Tumor Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca, Plc.
11.1.1 AstraZeneca, Plc. Company Details
11.1.2 AstraZeneca, Plc. Business Overview
11.1.3 AstraZeneca, Plc. Solid Tumor Cancer Treatment Introduction
11.1.4 AstraZeneca, Plc. Revenue in Solid Tumor Cancer Treatment Business (2016-2021)
11.1.5 AstraZeneca, Plc. Recent Development
11.2 Amgen, Inc.
11.2.1 Amgen, Inc. Company Details
11.2.2 Amgen, Inc. Business Overview
11.2.3 Amgen, Inc. Solid Tumor Cancer Treatment Introduction
11.2.4 Amgen, Inc. Revenue in Solid Tumor Cancer Treatment Business (2016-2021)
11.2.5 Amgen, Inc. Recent Development
11.3 B. Braun Melsungen AG
11.3.1 B. Braun Melsungen AG Company Details
11.3.2 B. Braun Melsungen AG Business Overview
11.3.3 B. Braun Melsungen AG Solid Tumor Cancer Treatment Introduction
11.3.4 B. Braun Melsungen AG Revenue in Solid Tumor Cancer Treatment Business (2016-2021)
11.3.5 B. Braun Melsungen AG Recent Development
11.4 Bristol Myers Squibb & Company
11.4.1 Bristol Myers Squibb & Company Company Details
11.4.2 Bristol Myers Squibb & Company Business Overview
11.4.3 Bristol Myers Squibb & Company Solid Tumor Cancer Treatment Introduction
11.4.4 Bristol Myers Squibb & Company Revenue in Solid Tumor Cancer Treatment Business (2016-2021)
11.4.5 Bristol Myers Squibb & Company Recent Development
11.5 Eli Lilly & Company
11.5.1 Eli Lilly & Company Company Details
11.5.2 Eli Lilly & Company Business Overview
11.5.3 Eli Lilly & Company Solid Tumor Cancer Treatment Introduction
11.5.4 Eli Lilly & Company Revenue in Solid Tumor Cancer Treatment Business (2016-2021)
11.5.5 Eli Lilly & Company Recent Development
11.6 F.Hoffman La-Roche Ltd.
11.6.1 F.Hoffman La-Roche Ltd. Company Details
11.6.2 F.Hoffman La-Roche Ltd. Business Overview
11.6.3 F.Hoffman La-Roche Ltd. Solid Tumor Cancer Treatment Introduction
11.6.4 F.Hoffman La-Roche Ltd. Revenue in Solid Tumor Cancer Treatment Business (2016-2021)
11.6.5 F.Hoffman La-Roche Ltd. Recent Development
11.7 Merck & Co., Inc.
11.7.1 Merck & Co., Inc. Company Details
11.7.2 Merck & Co., Inc. Business Overview
11.7.3 Merck & Co., Inc. Solid Tumor Cancer Treatment Introduction
11.7.4 Merck & Co., Inc. Revenue in Solid Tumor Cancer Treatment Business (2016-2021)
11.7.5 Merck & Co., Inc. Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Solid Tumor Cancer Treatment Introduction
11.8.4 Novartis Revenue in Solid Tumor Cancer Treatment Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 Pfizer, Inc.
11.9.1 Pfizer, Inc. Company Details
11.9.2 Pfizer, Inc. Business Overview
11.9.3 Pfizer, Inc. Solid Tumor Cancer Treatment Introduction
11.9.4 Pfizer, Inc. Revenue in Solid Tumor Cancer Treatment Business (2016-2021)
11.9.5 Pfizer, Inc. Recent Development
11.10 Olympus Medical Systems
11.10.1 Olympus Medical Systems Company Details
11.10.2 Olympus Medical Systems Business Overview
11.10.3 Olympus Medical Systems Solid Tumor Cancer Treatment Introduction
11.10.4 Olympus Medical Systems Revenue in Solid Tumor Cancer Treatment Business (2016-2021)
11.10.5 Olympus Medical Systems Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Solid Tumor Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Immunotherapy
Table 5. Key Players of Hormone Therapy
Table 6. Key Players of Surgical Procedures
Table 7. Global Solid Tumor Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Solid Tumor Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Solid Tumor Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Solid Tumor Cancer Treatment Market Share by Regions (2016-2021)
Table 11. Global Solid Tumor Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Solid Tumor Cancer Treatment Market Share by Regions (2022-2027)
Table 13. Solid Tumor Cancer Treatment Market Trends
Table 14. Solid Tumor Cancer Treatment Market Drivers
Table 15. Solid Tumor Cancer Treatment Market Challenges
Table 16. Solid Tumor Cancer Treatment Market Restraints
Table 17. Global Solid Tumor Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Solid Tumor Cancer Treatment Market Share by Players (2016-2021)
Table 19. Global Top Solid Tumor Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Solid Tumor Cancer Treatment as of 2020)
Table 20. Ranking of Global Top Solid Tumor Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Solid Tumor Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Solid Tumor Cancer Treatment Product Solution and Service
Table 24. Date of Enter into Solid Tumor Cancer Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Solid Tumor Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Solid Tumor Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Solid Tumor Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Solid Tumor Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Solid Tumor Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Solid Tumor Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Solid Tumor Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Solid Tumor Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Solid Tumor Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Solid Tumor Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Solid Tumor Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Solid Tumor Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Solid Tumor Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Solid Tumor Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Solid Tumor Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Solid Tumor Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Solid Tumor Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Solid Tumor Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Solid Tumor Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Solid Tumor Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Solid Tumor Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Solid Tumor Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Solid Tumor Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Solid Tumor Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Solid Tumor Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Solid Tumor Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Solid Tumor Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Solid Tumor Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Solid Tumor Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Solid Tumor Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Solid Tumor Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Solid Tumor Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Solid Tumor Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Solid Tumor Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Solid Tumor Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Solid Tumor Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Solid Tumor Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Solid Tumor Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. AstraZeneca, Plc. Company Details
Table 65. AstraZeneca, Plc. Business Overview
Table 66. AstraZeneca, Plc. Solid Tumor Cancer Treatment Product
Table 67. AstraZeneca, Plc. Revenue in Solid Tumor Cancer Treatment Business (2016-2021) & (US$ Million)
Table 68. AstraZeneca, Plc. Recent Development
Table 69. Amgen, Inc. Company Details
Table 70. Amgen, Inc. Business Overview
Table 71. Amgen, Inc. Solid Tumor Cancer Treatment Product
Table 72. Amgen, Inc. Revenue in Solid Tumor Cancer Treatment Business (2016-2021) & (US$ Million)
Table 73. Amgen, Inc. Recent Development
Table 74. B. Braun Melsungen AG Company Details
Table 75. B. Braun Melsungen AG Business Overview
Table 76. B. Braun Melsungen AG Solid Tumor Cancer Treatment Product
Table 77. B. Braun Melsungen AG Revenue in Solid Tumor Cancer Treatment Business (2016-2021) & (US$ Million)
Table 78. B. Braun Melsungen AG Recent Development
Table 79. Bristol Myers Squibb & Company Company Details
Table 80. Bristol Myers Squibb & Company Business Overview
Table 81. Bristol Myers Squibb & Company Solid Tumor Cancer Treatment Product
Table 82. Bristol Myers Squibb & Company Revenue in Solid Tumor Cancer Treatment Business (2016-2021) & (US$ Million)
Table 83. Bristol Myers Squibb & Company Recent Development
Table 84. Eli Lilly & Company Company Details
Table 85. Eli Lilly & Company Business Overview
Table 86. Eli Lilly & Company Solid Tumor Cancer Treatment Product
Table 87. Eli Lilly & Company Revenue in Solid Tumor Cancer Treatment Business (2016-2021) & (US$ Million)
Table 88. Eli Lilly & Company Recent Development
Table 89. F.Hoffman La-Roche Ltd. Company Details
Table 90. F.Hoffman La-Roche Ltd. Business Overview
Table 91. F.Hoffman La-Roche Ltd. Solid Tumor Cancer Treatment Product
Table 92. F.Hoffman La-Roche Ltd. Revenue in Solid Tumor Cancer Treatment Business (2016-2021) & (US$ Million)
Table 93. F.Hoffman La-Roche Ltd. Recent Development
Table 94. Merck & Co., Inc. Company Details
Table 95. Merck & Co., Inc. Business Overview
Table 96. Merck & Co., Inc. Solid Tumor Cancer Treatment Product
Table 97. Merck & Co., Inc. Revenue in Solid Tumor Cancer Treatment Business (2016-2021) & (US$ Million)
Table 98. Merck & Co., Inc. Recent Development
Table 99. Novartis Company Details
Table 100. Novartis Business Overview
Table 101. Novartis Revenue in Solid Tumor Cancer Treatment Business (2016-2021) & (US$ Million)
Table 102. Novartis Recent Development
Table 103. Pfizer, Inc. Company Details
Table 104. Pfizer, Inc. Business Overview
Table 105. Pfizer, Inc. Solid Tumor Cancer Treatment Product
Table 106. Pfizer, Inc. Revenue in Solid Tumor Cancer Treatment Business (2016-2021) & (US$ Million)
Table 107. Pfizer, Inc. Recent Development
Table 108. Olympus Medical Systems Company Details
Table 109. Olympus Medical Systems Business Overview
Table 110. Olympus Medical Systems Solid Tumor Cancer Treatment Product
Table 111. Olympus Medical Systems Revenue in Solid Tumor Cancer Treatment Business (2016-2021) & (US$ Million)
Table 112. Olympus Medical Systems Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Solid Tumor Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Targeted Therapy Features
Figure 4. Immunotherapy Features
Figure 5. Hormone Therapy Features
Figure 6. Surgical Procedures Features
Figure 7. Global Solid Tumor Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 8. Breast Cancer Case Studies
Figure 9. Cervical Cancer Case Studies
Figure 10. Colorectal Cancer Case Studies
Figure 11. Lung Cancer Case Studies
Figure 12. Prostate Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. Solid Tumor Cancer Treatment Report Years Considered
Figure 15. Global Solid Tumor Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Solid Tumor Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Solid Tumor Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 18. Global Solid Tumor Cancer Treatment Market Share by Regions (2022-2027)
Figure 19. Global Solid Tumor Cancer Treatment Market Share by Players in 2020
Figure 20. Global Top Solid Tumor Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Solid Tumor Cancer Treatment as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Solid Tumor Cancer Treatment Revenue in 2020
Figure 22. Global Solid Tumor Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 23. Global Solid Tumor Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 24. North America Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Solid Tumor Cancer Treatment Market Share by Type (2016-2027)
Figure 26. North America Solid Tumor Cancer Treatment Market Share by Application (2016-2027)
Figure 27. North America Solid Tumor Cancer Treatment Market Share by Country (2016-2027)
Figure 28. United States Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Solid Tumor Cancer Treatment Market Share by Type (2016-2027)
Figure 32. Europe Solid Tumor Cancer Treatment Market Share by Application (2016-2027)
Figure 33. Europe Solid Tumor Cancer Treatment Market Share by Country (2016-2027)
Figure 34. Germany Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Solid Tumor Cancer Treatment Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Solid Tumor Cancer Treatment Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Solid Tumor Cancer Treatment Market Share by Region (2016-2027)
Figure 44. China Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Solid Tumor Cancer Treatment Market Share by Type (2016-2027)
Figure 52. Latin America Solid Tumor Cancer Treatment Market Share by Application (2016-2027)
Figure 53. Latin America Solid Tumor Cancer Treatment Market Share by Country (2016-2027)
Figure 54. Mexico Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Solid Tumor Cancer Treatment Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Solid Tumor Cancer Treatment Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Solid Tumor Cancer Treatment Market Share by Country (2016-2027)
Figure 60. Turkey Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Solid Tumor Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. AstraZeneca, Plc. Revenue Growth Rate in Solid Tumor Cancer Treatment Business (2016-2021)
Figure 64. Amgen, Inc. Revenue Growth Rate in Solid Tumor Cancer Treatment Business (2016-2021)
Figure 65. B. Braun Melsungen AG Revenue Growth Rate in Solid Tumor Cancer Treatment Business (2016-2021)
Figure 66. Bristol Myers Squibb & Company Revenue Growth Rate in Solid Tumor Cancer Treatment Business (2016-2021)
Figure 67. Eli Lilly & Company Revenue Growth Rate in Solid Tumor Cancer Treatment Business (2016-2021)
Figure 68. F.Hoffman La-Roche Ltd. Revenue Growth Rate in Solid Tumor Cancer Treatment Business (2016-2021)
Figure 69. Merck & Co., Inc. Revenue Growth Rate in Solid Tumor Cancer Treatment Business (2016-2021)
Figure 70. Novartis Revenue Growth Rate in Solid Tumor Cancer Treatment Business (2016-2021)
Figure 71. Pfizer, Inc. Revenue Growth Rate in Solid Tumor Cancer Treatment Business (2016-2021)
Figure 72. Olympus Medical Systems Revenue Growth Rate in Solid Tumor Cancer Treatment Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

以下、関連資料のご紹介

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の神経内分泌腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Neuroendocrine Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4567 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、神経内分泌腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エベロリムス、スニチニブ、ドタオクトレオテート、ランレオチド、オクトレオチド）、用途別市場規模（病院、クリニック、その他）、主要地域別...

世界の線維形成性小円形細胞腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Desmoplastic Small Round Cell Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4116 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、線維形成性小円形細胞腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫療法、外科手術、化学療法、放射線療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界のデスモイド腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Desmoid Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4115 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、デスモイド腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医療処置、投薬）、用途別市場規模（病院、診療所、ASC、在宅医療、学術研究センター、私立研究所）、主要地域別市場規模（北米、アメリカ、...

世界の犬乳腺腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Canine Mammary Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3963 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、犬乳腺腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（腺腫、癌腫、腺癌）、用途別市場規模（獣医病院、獣医クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のがん腫瘍プロファイリング市場規模・現状・予測（2021年-2027年）

Global Cancer Tumor Profiling Market Size, Status and Forecast 2021-2027
QFJ1-3960 2021年6月 120Pages
QYResearch社発行の本調査レポートでは、がん腫瘍プロファイリングの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（次世代シーケンシング（NGS）、ポリメラーゼ連鎖反応（PCR）、免疫組織化学（IHC）、インサイツハイブリダイゼーション（ISH...

世界の転移性膵がん治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Pancreatic Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4499 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、転移性膵がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法、その他）、用途別市場規模（外分泌、内分泌）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の去勢抵抗性前立腺がん治療市場規模・現状・予測（2021年-2027年）

Global Castrate-resistant Prostate Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3976 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、去勢抵抗性前立腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、ホルモン療法、免疫療法、放射線療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の腫瘍ラジオ波焼灼療法市場規模・現状・予測（2021年-2027年）

Global Tumor Radiofrequency Ablation Market Size, Status and Forecast 2021-2027
QFJ1-6056 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、腫瘍ラジオ波焼灼療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肺がん、腎臓がん、乳がん、前立腺がん、肝臓がん、その他）、用途別市場規模（病院、がん専門クリニック、その他）、主要地域別市場規模（北...

世界の転移性乳がん治療市場規模・現状・予測（2021年-2027年） Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…
世界の肺がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Lung Cancer Therapy Market The global Lung Cancer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report mak…
世界の去勢抵抗性前立腺がん治療市場規模・現状・予測（2021年-2027年） Prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels. Many early-stage prostate cancers need normal levels of testosterone to grow, but castrate-resistant prostate cancers do not. Also called CRPC. Market Analysis and Insights: Global Cast…
世界のがんホルモン療法剤市場規模・現状・予測（2021年-2027年） Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer. Market Analysis and Insights: Global Cancer H…
世界の結腸直腸癌治療市場規模・現状・予測（2021年-2027年） Colorectal cancer therapeutics market trends, there are a number of factors providing major impetus to the growth of these drugs. Market Analysis and Insights: Global Colorectal Cancer Treatment Market The global Colorectal Cancer Treatment market size is projected to reach US$ XX million by 2027, f…